A minimally invasive treatment that targets only cancerous tissue in the prostate may offer the same chance of treating localized prostate cancer as surgery or radiotherapy while causing significantly ...

While the use of focal therapy for nonmetastatic prostate cancer is limited, half of procedures occurred in settings that are not supported by current guidelines, according to a retrospective study.

For patients with nonmetastatic prostate cancer, focal therapy use has remained uncommon across risk groups, and its use was defined as inappropriate in about half of recipients, according to a ...

Phase 2 PFLT-PC data revealed no significant disease was seen in 84% of patients treated with cooled laser focal therapy for prostate cancer at 3 months. Early outcomes from the phase 2 ProFocal Laser ...

A prostate cancer diagnosis can leave men weighing several consequential decisions, from active surveillance and regular monitoring to surgery and radiation therapy.

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

In 1948, researchers stressed a nursing mother with ice water, toe pulling, and math problems with shocks. Each time, her baby got less milk. The Old Farmer's Almanac predicts snow in the Upper ...

Mina Fam, MD, explored the integration of multiparametric MRI and genomics in focal HIFU selection and compared its AE profile to radical intervention. The emergence of high-intensity focused ...

A minimally invasive targeted treatment called salvage focal therapy, which targets just the cancerous area of the prostate, can treat men whose prostate cancer has recurred after radiotherapy with ...

Vaccines.gov's ZIP code search is not working as flu season starts. Here is how to find flu, COVID, and RSV shots at pharmacies and health centers. Sandoz will pay $400 million to settle state claims ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

Current guidelines recommend that focal therapy be reserved for patients with intermediate-risk prostate cancer within clinical trials or prospective registries. In a retrospective study, half of ...